Details

Autor(en) / Beteiligte

• Naqvi, Raza Ali
• Valverde, Araceli
• Yadavalli, Tejabhiram
• Bobat, Fatima Ismail
• Capistrano, Kristelle J
• Shukla, Deepak
• Naqvi, Afsar R

Titel

Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology

Ist Teil von

• Current pharmaceutical design, 2024-01, Vol.30 (9), p.649

Ort / Verlag

United Arab Emirates

Erscheinungsjahr

2024

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• (Herpes simplex virus type 1 [HSV-1]) infects millions of people globally, manifesting as vesiculo-ulcerative lesions of the oral or genital mucosa. After primary infection, the virus establishes latency in the peripheral neurons and reactivates sporadically in response to various environmental and genetic factors. A unique feature of herpesviruses is their ability to encode tiny noncoding RNAs called microRNA (miRNAs). encodes eighteen miRNA precursors that generate twentyseven different mature miRNA sequences. Unique miRNAs repertoire is expressed in lytic and latent stages and exhibits expressional disparity in various cell types and model systems, suggesting their key pathological functions. This review will focus on elucidating the mechanisms underlying the regulation of host-virus interaction by HSV-1 encoded viral miRNAs. Numerous studies have demonstrated sequence- specific targeting of both viral and host transcripts by miRNAs. While these noncoding RNAs predominantly target viral genes involved in viral life cycle switch, they regulate host genes involved in antiviral immunity, thereby facilitating viral evasion and lifelong viral persistence inside the host. Expression of miRNAs has been associated with disease progression and resolution. Systemic circulation and stability of viral miRNAs compared to viral mRNAs can be harnessed to utilize their potential as diagnostic and prognostic markers. Moreover, functional inhibition of these enigmatic molecules may allow us to devise strategies that have therapeutic significance to contain infection.